Ensemble machine learning for predicting in-hospital mortality in Asian women with ST-elevation myocardial infarction (STEMI).
Source check: Source checked. Not independent scientific confirmation.
Finding: publisher full text verifies ensemble ML trained/tested on Malaysian registry cases to predict in-hospital mortality in women with STEMI and compared with TIMI; registry split is internal only.
Technology: An ensemble of machine-learning models uses Malaysian STEMI registry data to predict in-hospital mortality in women with STEMI and is compared with TIMI.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- An ensemble of machine-learning models uses Malaysian STEMI registry data to predict in-hospital mortality in women with STEMI and is compared with TIMI.
- Test and result
- The study reports registry-based mortality prediction with an internal train/test split and comparison against TIMI.
- Limitation / still unknown
- The split is internal to one registry; external prospective validation and clinical impact are unestablished.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/38811643 · https://www.nature.com/articles/s41598-024-61151-x.pdf · https://pubmed.ncbi.nlm.nih.gov/38811643/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.